{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3B+placebo+comparator+condition&page=4", "query": { "intervention": "Placebo; placebo comparator condition", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 7763, "total_pages": 777, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3B+placebo+comparator+condition&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3B+placebo+comparator+condition&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T18:22:00.316Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03369236", "title": "A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "C3 Glomerulopathy", "C3 Glomerulonephritis", "Dense Deposit Disease" ], "interventions": [ { "name": "Danicopan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "17 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "17 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2018-06-12", "completion_date": "2020-12-18", "has_results": true, "last_update_posted_date": "2022-10-14", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 6, "location_summary": "Aurora, Colorado • Lawrenceville, Georgia • Iowa City, Iowa + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Lawrenceville", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03369236" }, { "nct_id": "NCT05928936", "title": "Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "Sodium Bicarbonate", "type": "DRUG" }, { "name": "Exercise Training", "type": "BEHAVIORAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 156, "start_date": "2022-11-11", "completion_date": "2028-06-01", "has_results": false, "last_update_posted_date": "2025-10-21", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Decatur, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05928936" }, { "nct_id": "NCT05611671", "title": "A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Inflammatory Bowel Diseases", "Colitis, Ulcerative" ], "interventions": [ { "name": "MORF-057", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 280, "start_date": "2022-11-21", "completion_date": "2026-08", "has_results": true, "last_update_posted_date": "2025-12-15", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 8, "location_summary": "Sun City, Arizona • Lancaster, California • Los Angeles, California + 5 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05611671" }, { "nct_id": "NCT01218516", "title": "A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Adenocarcinoma of the Lung" ], "interventions": [ { "name": "Farletuzumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "OTHER", "DRUG" ], "sponsor": "Morphotek", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 130, "start_date": "2011-06-27", "completion_date": "2013-11-01", "has_results": true, "last_update_posted_date": "2020-08-20", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 54, "location_summary": "Chandler, Arizona • Glendale, Arizona • Beverly Hills, California + 50 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Gilroy", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01218516" }, { "nct_id": "NCT00040404", "title": "Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "CEP-1347 10mg", "type": "DRUG" }, { "name": "CEP1347 25mg", "type": "DRUG" }, { "name": "CEP-1347 50mg", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Cephalon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 806, "start_date": "2002-03", "completion_date": "2005-08", "has_results": false, "last_update_posted_date": "2012-05-10", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 56, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 46 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00040404" }, { "nct_id": "NCT04223349", "title": "A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "JNJ-70033093", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 66, "start_date": "2020-01-10", "completion_date": "2020-04-08", "has_results": false, "last_update_posted_date": "2025-04-27", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04223349" }, { "nct_id": "NCT07369115", "title": "Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Diorder", "Early Life Trauma" ], "interventions": [ { "name": "Lumateperone 42 mg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 50, "start_date": "2026-02", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-01-27", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07369115" }, { "nct_id": "NCT04497168", "title": "Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "Citalopram 20mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 58, "start_date": "2021-04-01", "completion_date": "2026-03-02", "has_results": false, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04497168" }, { "nct_id": "NCT04724668", "title": "The Role of the Circadian System in Binge Eating Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Binge-Eating Disorder", "Circadian Rhythm Disorders" ], "interventions": [ { "name": "Melatonin (3hrs before DLMO)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo (3hrs before DLMO)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Morning light version 1", "type": "DEVICE" }, { "name": "Morning light version 2", "type": "DEVICE" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 84, "start_date": "2021-01-15", "completion_date": "2025-05-30", "has_results": true, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 1, "location_summary": "Mason, Ohio", "locations": [ { "city": "Mason", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04724668" }, { "nct_id": "NCT02006290", "title": "Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "PF-06412562", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "30 Years to 75 Years" }, "enrollment_count": 19, "start_date": "2014-03", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2015-10-02", "last_synced_at": "2026-10-11T18:22:00.316Z", "location_count": 5, "location_summary": "Aventura, Florida • Baco Raton, Florida • South Miami, Florida + 2 more", "locations": [ { "city": "Aventura", "state": "Florida" }, { "city": "Baco Raton", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Bingham Farms", "state": "Michigan" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02006290" } ] }